Vaxcyte, Inc.PCVXNASDAQ
Loading
Year-over-year research & development expense growth
3Y CAGR
-16.9%/yr
vs -3.8%/yr prior
5Y CAGR
+1.7%/yr
Recent deceleration
Acceleration
-13.1pp
Decelerating
Percentile
P63
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 66.65% |
| 2024 | 43.42% |
| 2023 | 96.13% |
| 2022 | 116.11% |
| 2021 | 6.59% |
| 2020 | 61.30% |
| 2019 | 51.29% |
| 2018 | 135.78% |
| 2017 | 0.00% |